Nigel H Greig

USPTO Granted Patents = 27 (Patent Applications = 3)

CIPO Patents = 7 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 5.4

ph-index = 11

Forward Citations = 265(Granted Patents)

Location History:

Washington, DC (US) (1989)
Silver Spring, MD (US) (1992 - 2006)
Phoenix, MD (US) (2002 - 2023)

Company Filing History:

16 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

The United States of America As Represented by the Secretary of

patents

4. 3 out of 49

The University Court of the University of Aberdeen

patents

5. 2 out of 1,215

The United States of America As Represented by the Department of Health

patents

6. 2 out of 6

Raptor Pharmaceutical Corp

patents

7. 2 out of 30

National Institutes of Health (nih)

The National Institutes of Health and Axonyx, Inc.

patent

11. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2023

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11771657 - Methods of delivering a neuroprotective polypeptide to the central nervous system (2023-10-03),

2. 11440880 - Thalidomide analogs and methods of use (2022-09-13),

3. 11273130 - Methods of delivering a neuroprotective polypeptide to the central nervous system (2022-03-15),

4. 10941187 - GLP-1, exendin-4, peptide analogs and uses thereof (2021-03-09),

5. 10836721 - Thalidomide analogs and methods of use (2020-11-17),

6. 10730835 - Thalidomide analogs and methods of use (2020-08-04),

7. 10220028 - Thio compounds (2019-03-05),

8. 9623020 - Thio compounds (2017-04-18),

9. 8927725 - Thio compounds (2015-01-06),

10. 8853253 - Thalidomide analogs (2014-10-07),

11. 8853160 - GLP-1, exendin-4, peptide analogs and uses thereof (2014-10-07),

12. 8691864 - Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof (2014-04-08),

13. 8546430 - Thalidomide analogs (2013-10-01),

14. 8278272 - GLP-1, exendin-4, peptide analogs and uses thereof (2012-10-02),

15. 8258172 - Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof (2012-09-04),

Title: Inventor Nigel H Greig - Pioneering Innovations in Phoenix, MD

Introduction: Nigel H Greig is a distinguished inventor based in Phoenix, MD, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Nigel H Greig holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: Throughout his illustrious career, Nigel H Greig has been recognized for his ability to transform ideas into tangible solutions that have a positive impact on society. His dedication to pushing the boundaries of innovation has led to the development of cutting-edge products that have revolutionized their respective industries.

Collaborations: Nigel H Greig has collaborated with leading research institutions, universities, and companies to further enhance the impact of his inventions. His collaborative spirit and passion for innovation have resulted in successful partnerships that have accelerated the development and commercialization of his creations.

Conclusion: Nigel H Greig's relentless pursuit of innovation and his commitment to creating a better future through his inventions have solidified his reputation as a visionary inventor in Phoenix, MD, and beyond.

This text is generated by artificial intelligence and may not be accurate.